casino with free sign up bonus

Suchir Balaji, a former OpenAI engineer and whistleblower who helped train the artificial intelligence systems behind ChatGPT and later said he believed those practices violated copyright law, has died, according to his parents and San Francisco officials. He was 26. Balaji worked at OpenAI for nearly four years before quitting in August. He was well-regarded by colleagues at the San Francisco company, where a co-founder this week called him one of OpenAI's strongest contributors who was essential to developing some of its products. “We are devastated to learn of this incredibly sad news and our hearts go out to Suchir’s loved ones during this difficult time,” said a statement from OpenAI. Balaji was found dead in his San Francisco apartment on Nov. 26 in what police said “appeared to be a suicide. No evidence of foul play was found during the initial investigation.” The city's chief medical examiner's office confirmed the manner of death to be suicide. His parents Poornima Ramarao and Balaji Ramamurthy said they are still seeking answers, describing their son as a “happy, smart and brave young man” who loved to hike and recently returned from a trip with friends. Balaji grew up in the San Francisco Bay Area and first arrived at the fledgling AI research lab for a 2018 summer internship while studying computer science at the University of California, Berkeley. He returned a few years later to work at OpenAI, where one of his first projects, called WebGPT, helped pave the way for ChatGPT. “Suchir’s contributions to this project were essential, and it wouldn’t have succeeded without him,” said OpenAI co-founder John Schulman in a social media post memorializing Balaji. Schulman, who recruited Balaji to his team, said what made him such an exceptional engineer and scientist was his attention to detail and ability to notice subtle bugs or logical errors. “He had a knack for finding simple solutions and writing elegant code that worked,” Schulman wrote. “He’d think through the details of things carefully and rigorously.” Balaji later shifted to organizing the huge datasets of online writings and other media used to train GPT-4, the fourth generation of OpenAI's flagship large language model and a basis for the company's famous chatbot. It was that work that eventually caused Balaji to question the technology he helped build, especially after newspapers, novelists and others began suing OpenAI and other AI companies for copyright infringement. He first raised his concerns with The New York Times, which reported them in an October profile of Balaji . He later told The Associated Press he would “try to testify” in the strongest copyright infringement cases and considered a lawsuit brought by The New York Times last year to be the “most serious.” Times lawyers named him in a Nov. 18 court filing as someone who might have “unique and relevant documents” supporting allegations of OpenAI's willful copyright infringement. His records were also sought by lawyers in a separate case brought by book authors including the comedian Sarah Silverman, according to a court filing. “It doesn’t feel right to be training on people’s data and then competing with them in the marketplace,” Balaji told the AP in late October. “I don’t think you should be able to do that. I don’t think you are able to do that legally.” He told the AP that he gradually grew more disillusioned with OpenAI, especially after the internal turmoil that led its board of directors to fire and then rehire CEO Sam Altman last year. Balaji said he was broadly concerned about how its commercial products were rolling out, including their propensity for spouting false information known as hallucinations. But of the “bag of issues” he was concerned about, he said he was focusing on copyright as the one it was “actually possible to do something about.” He acknowledged that it was an unpopular opinion within the AI research community, which is accustomed to pulling data from the internet, but said “they will have to change and it’s a matter of time.” He had not been deposed and it’s unclear to what extent his revelations will be admitted as evidence in any legal cases after his death. He also published a personal blog post with his opinions about the topic. Schulman, who resigned from OpenAI in August, said he and Balaji coincidentally left on the same day and celebrated with fellow colleagues that night with dinner and drinks at a San Francisco bar. Another of Balaji’s mentors, co-founder and chief scientist Ilya Sutskever, had left OpenAI several months earlier , which Balaji saw as another impetus to leave. Schulman said Balaji had told him earlier this year of his plans to leave OpenAI and that Balaji didn't think that better-than-human AI known as artificial general intelligence “was right around the corner, like the rest of the company seemed to believe.” The younger engineer expressed interest in getting a doctorate and exploring “some more off-the-beaten path ideas about how to build intelligence,” Schulman said. Balaji's family said a memorial is being planned for later this month at the India Community Center in Milpitas, California, not far from his hometown of Cupertino. —————- EDITOR’S NOTE — This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988. —————-- The Associated Press and OpenAI have a licensing and technology agreement allowing OpenAI access to part of the AP’s text archives.TERRYVILLE – Waldermar “Wally” Ward, 71, of Terryville, passed away Dec. 5, 2024, peacefully at the side of his significant other of 24 years, Melanie Adamowich. Wally was born in Germany on Oct. 6, 1953, the son of the late Harvey and Hannelore (Murth) Ward. Fondly known to called Wally, this kind soul was a genuine person and friend in both heart and mind. He was loved and cared for as he pursued and achieved his life’s purpose of perfecting his game of golf; especially for almost a decade of consistent club championship wins at Pequabuck Golf Club. Wally was a proud member of his commitment toward practicing/playing golf and served as treasurer of the club. He was very proud of winning three club championships at Pequabuck in 2019. Wally’s two fur-boys and Melanie will miss him dearly, but he lives on in our hearts forever. He leaves a son, Jason and his wife Kelly, granddaughter Olivia, of Vernon; sister Angelika Donavan, of Watertown; aunt Anna Darm of Naugatuck; nephews and nieces; and significant other Melanie Adamowich of Terryville. No services at this time. The Dunn Funeral Home, 191 West St., Bristol, is in charge of the arrangements. Dunnfh.com.Fans of I'm A Celebrity have teased this week that host Ant McPartlin appears to dislike one of the campmates. Sunday's episode saw Ant, 49, and co-host Dec Donnelly , 49, come face-to-face with campmate Dean McCullough , 32, once again at a bushtucker trial. It marked the radio host's fifth trial on the new series of the ITV show so far. BBC Radio 1 presenter Dean poked fun at having been voted to do several trials when he arrived at the trial area with Coleen Rooney , who was doing the trial with him. He told the hosts upon seeing them again: "We need to stop meeting like this." Dec laughed, whilst Ant appeared to sport a smile. Dean added: "I told ya I didn't want another date." Ant did appear to laugh briefly before returning to a similar expression as before, as Dec commented: "Our fifth date now at the bushtucker trial clearing." READ MORE: Maura Higgins shares disgusting way she got revenge on sleazy ex READ MORE: Molly-Mae Hague shares first Christmas plans without Tommy amid concern for Bambi Following the scenes and amid the trial, fans took to X, formerly known as Twitter , to share their thoughts. Several viewers teased that host Ant appears to dislike Dean, with one writing: "Ant literally looks like he hates Dean." Another commented: "Ant hates Dean so much omg. His face says it all." A third tweeted: "Ant can't stand Dean you can tell." Whilst someone else wrote on Sunday night: "You can tell straight away Ant doesn't like Dean at all." Sharing their thoughts, another viewer wrote: "Ant's expression when looking at Dean is 'barely concealed disdain'." Alongside a laughing emoji, one fan said: "He f***ing loathes him." Another teased: "Ant's face when Dean said I told you I didn't want [another date]." Whilst someone else said: "Ant going over and above to try and be nice to Dean because we've caught on that he doesn't like him is TV GOLD." Following the episode, Ant encouraged viewers to stop voting for Dean to give other celebrities a chance to take part in future trials. Dean has taken part in the majority of trials so far and has at times struggled to win stars. It was announced on Sunday night that Dean - who won nine stars with Coleen - will do the next trial too. During the latest episode of the companion show I'm A Celebrity... Unpacked, host Joel Dommett asked Ant: "What do you think about Dean doing the trial again tomorrow?" Ant replied with a message for viewers at home: "Right. Let's all have a serious talk. I'm going to look directly into the camera here. I think it's good to see other faces down there." Ant continued: "This is not a personal thing. It's not about Dean, it's about us just seeing different people down there. And I think we want to see different people on the show being featured. Some people unfortunately aren't getting [screen time]." The presenter went on to name Barry McGuigan , Melvin Odoom and Oti Mabuse as examples of other campmates he would want to see take part in a future trial. It comes after Ant admitted earlier this week that his "annoyance came across onscreen" during a previous trial that Dean quit after winning four stars. Speaking on Unpacked, Ant teased: "My annoyance came across onscreen. I was unprofessional. I'm not happy about it." The comments followed speculation among viewers on social media that Ant had been frustrated by Dean in the trial. I'm A Celebrity...Get Me Out Of Here! airs every night at 9pm on Virgin Media One, Virgin Media Play, ITV1, STV and ITVX. Companion show I'm A Celebrity...Unpacked airs live on ITV2 directly afterwards . Follow Mirro r C elebs on TikTok , Snapchat , Instagram , Twitter , Facebook , YouTube and Threads . Join the Irish Mirror’s breaking news service on WhatsApp. Click this link to receive breaking news and the latest headlines direct to your phone. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don’t like our community, you can check out any time you like. If you’re curious, you can read our Privacy Notice .casino with free sign up bonus 。

Rico Carty, Former NL Batting Champ, Dies At 85

Martin Marietta Materials Inc. stock rises Thursday, outperforms marketChris Mubiru leads Northwestern State over North Alabama 71-58

Dr Firdausi Qadri Dr Firdausi Qadri, senior scientist at icddr,b and a globally recognized expert in infectious disease prevention, has been awarded the prestigious 2024 VinFuture Special Prize for innovators in developing countries. This honour acknowledges her pioneering contributions to the development and dissemination of affordable vaccines for cholera, typhoid, and HPV, says a press release issued by icddr,b on Saturday. According to icddr,b, the award ceremony was held on Friday evening at the Ho Guom Opera House in Hanoi, Vietnam, in the presence of Vietnam’s Prime Minister Pham Minh Chinh. The event was also attended by Pham Nhat Vuong, chairman of Vingroup and founder of the VinFuture Foundation, along with Madam Pham Thu Huong, vice chairperson of Vingroup’s board of directors and co-founder of the VinFuture Foundation. Established to honor innovations that transform lives and build a sustainable future, the VinFuture Prize received nominations from nearly 1,500 individuals across over 80 countries and regions this year. Dr Qadri’s 2024 award aligns with the theme "Resilient Rebound," which recognizes resilience and progress through scientific excellence. After receiving the award, Dr Qadri expressed her gratitude, highlighting her career spanning over four decades in public health. She said: "I am deeply honored to receive the VinFuture Prize for innovations in developing countries. For more than four decades, my work has focused on combating infectious diseases, particularly cholera, typhoid, and HPV, ensuring affordable vaccines reach the communities most in need. With the support of such recognition, I have been able to expand my efforts to address other critical health challenges in Bangladesh. This award is not just a personal achievement but also a testament to my team at icddr,b, my institution, and the power of science to enhance quality of life and build a more equitable world." The Grand Prize was jointly awarded to Professor Yoshua Bengio, Professor Geoffrey Everest Hinton, Jensen Huang, and Yann LeCun for their groundbreaking contributions to deep learning. Their revolutionary work has transformed artificial intelligence (AI), enabling significant advancements in fields such as healthcare, autonomous systems, and environmental science, highlighting AI's immense potential to improve lives globally. The VinFuture Prize, one of the most prestigious science and technology awards globally, includes a Grand Prize of $3 million and three Special Prizes of $500,000 each. These special prizes recognize innovators in developing countries, female innovators, and innovators in emerging fields. The foundation aims to advance science and technology for equitable and sustainable development. The award ceremony also featured a special performance by Grammy Award-winning band Imagine Dragons, further elevating the celebratory atmosphere of this landmark event.TransMedics Group, Inc. ( NASDAQ:TMDX – Get Free Report ) traded down 5% on Friday . The company traded as low as $72.68 and last traded at $75.39. 748,139 shares were traded during mid-day trading, a decline of 24% from the average session volume of 982,771 shares. The stock had previously closed at $79.34. Analyst Upgrades and Downgrades A number of analysts recently commented on the company. Needham & Company LLC reaffirmed a “hold” rating and set a $109.00 price objective on shares of TransMedics Group in a research note on Friday. Canaccord Genuity Group decreased their price target on shares of TransMedics Group from $109.00 to $104.00 and set a “buy” rating on the stock in a research note on Wednesday. Oppenheimer cut their price objective on shares of TransMedics Group from $200.00 to $125.00 and set an “outperform” rating for the company in a research report on Tuesday, October 29th. Stephens raised their target price on shares of TransMedics Group from $151.00 to $178.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Finally, Robert W. Baird lowered their target price on shares of TransMedics Group from $200.00 to $150.00 and set an “outperform” rating for the company in a research note on Tuesday, October 29th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $131.80. Check Out Our Latest Stock Analysis on TMDX TransMedics Group Stock Performance TransMedics Group ( NASDAQ:TMDX – Get Free Report ) last issued its earnings results on Monday, October 28th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.17). TransMedics Group had a return on equity of 18.74% and a net margin of 8.14%. The firm had revenue of $108.76 million during the quarter, compared to analysts’ expectations of $115.00 million. During the same period last year, the business posted ($0.12) earnings per share. The company’s quarterly revenue was up 63.7% compared to the same quarter last year. Equities research analysts anticipate that TransMedics Group, Inc. will post 1 EPS for the current year. Insider Activity In related news, insider Tamer I. Khayal sold 2,958 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $148.24, for a total value of $438,493.92. Following the completion of the sale, the insider now directly owns 20,843 shares in the company, valued at approximately $3,089,766.32. This represents a 12.43 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . Also, insider Nicholas Corcoran sold 10,000 shares of the business’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $176.02, for a total value of $1,760,200.00. Following the transaction, the insider now owns 21,105 shares in the company, valued at approximately $3,714,902.10. This represents a 32.15 % decrease in their position. The disclosure for this sale can be found here . Insiders have sold 36,958 shares of company stock valued at $5,230,528 in the last three months. Corporate insiders own 7.00% of the company’s stock. Institutional Investors Weigh In On TransMedics Group Hedge funds have recently modified their holdings of the stock. Vaughan Nelson Investment Management L.P. purchased a new position in TransMedics Group in the 2nd quarter worth approximately $39,862,000. Driehaus Capital Management LLC raised its stake in shares of TransMedics Group by 15.8% during the second quarter. Driehaus Capital Management LLC now owns 1,486,073 shares of the company’s stock valued at $223,832,000 after purchasing an additional 202,867 shares during the period. Principal Financial Group Inc. lifted its position in shares of TransMedics Group by 260.1% during the third quarter. Principal Financial Group Inc. now owns 202,287 shares of the company’s stock worth $31,759,000 after purchasing an additional 146,115 shares in the last quarter. Hood River Capital Management LLC purchased a new position in shares of TransMedics Group in the second quarter valued at $18,854,000. Finally, Canada Pension Plan Investment Board acquired a new stake in TransMedics Group during the 2nd quarter valued at $16,086,000. 99.67% of the stock is currently owned by hedge funds and other institutional investors. TransMedics Group Company Profile ( Get Free Report ) TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Featured Articles Receive News & Ratings for TransMedics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransMedics Group and related companies with MarketBeat.com's FREE daily email newsletter .

PNC Financial Services Group Inc. trimmed its holdings in Shopify Inc. ( NYSE:SHOP – Free Report ) (TSE:SHOP) by 2.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 93,107 shares of the software maker’s stock after selling 2,382 shares during the period. PNC Financial Services Group Inc.’s holdings in Shopify were worth $7,462,000 as of its most recent filing with the Securities and Exchange Commission. Several other institutional investors have also made changes to their positions in the stock. Oliver Lagore Vanvalin Investment Group raised its position in shares of Shopify by 100.0% in the 2nd quarter. Oliver Lagore Vanvalin Investment Group now owns 400 shares of the software maker’s stock valued at $26,000 after buying an additional 200 shares in the last quarter. Cultivar Capital Inc. bought a new stake in Shopify during the second quarter worth $33,000. Hazlett Burt & Watson Inc. acquired a new stake in shares of Shopify in the 2nd quarter valued at $33,000. Rosenberg Matthew Hamilton increased its stake in shares of Shopify by 41.3% in the 3rd quarter. Rosenberg Matthew Hamilton now owns 455 shares of the software maker’s stock valued at $36,000 after purchasing an additional 133 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Shopify during the 2nd quarter worth $39,000. 69.27% of the stock is currently owned by institutional investors. Shopify Stock Up 0.5 % Shopify stock opened at $106.96 on Friday. The firm has a 50 day moving average price of $85.50 and a 200-day moving average price of $72.12. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.09. Shopify Inc. has a twelve month low of $48.56 and a twelve month high of $115.62. The company has a market capitalization of $138.02 billion, a P/E ratio of 99.96, a P/E/G ratio of 2.80 and a beta of 2.36. Wall Street Analyst Weigh In Get Our Latest Report on SHOP About Shopify ( Free Report ) Shopify Inc, a commerce company, provides a commerce platform and services in Canada, the United States, Europe, the Middle East, Africa, the Asia Pacific, Australia, China, and Latin America. The company’s platform enables merchants to displays, manages, markets, and sells its products through various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, manage cash, payments and transactions, and access financing. Featured Stories Want to see what other hedge funds are holding SHOP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shopify Inc. ( NYSE:SHOP – Free Report ) (TSE:SHOP). Receive News & Ratings for Shopify Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shopify and related companies with MarketBeat.com's FREE daily email newsletter .With technical prowess and considerable style, Marta danced around two sliding defenders, outwitted a goalkeeper and calmly scored as another player rushed forward in desperation to stop her. It was more Marta Magic. That goal last weekend helped propel the Orlando Pride into Saturday's National Women's Soccer League championship game against the Washington Spirit. Barbra Banda also scored in the Pride's 3-2 semifinal victory over the Kansas City Current . While Banda has had an incredible first season with the Pride, captain Marta has been the talisman that has helped lead the team in its remarkable turnaround this year. The last time the Pride were in the NWSL playoffs was in 2017 — Marta's first year with the club. But this season they nearly went undefeated, going 23 games without a loss to start the season before losing 2-0 to the Portland Thorns with just two regular-season games left. “I think because of the way that we did it, during this season, from beginning to now, it’s something very special that I’ve never had before with any other club that I’ve played for," Marta said. "Plus year by year, we see in America, strong competition. This is the best league in the world. And you never know what’s going to happen, and it’s hard to keep winning the games, being in the first place almost like the whole season. That’s why it’s really different and so special.” Marta’s goal was the latest gasp-inducing moment in a stellar career filled with them. Known by just her first name, the 38-year-old is a six-time FIFA world player of the year. "Let's see if tomorrow I can do something similar — or even better," Marta said on Friday. Her teammate Kylie Strom chimed in: “That was the greatest goal I've ever witnessed, hands down." Appropriate. Earlier this year, FIFA announced that the best goal in women's soccer each year would earn the Marta Award. In a lighthearted moment the day before the title match, Marta was asked if she thought it was possible she might give the award to herself. “You guys need to decide, because who votes for the best goal in the year? It’s you. It’s the people in the public. So it should be really interesting, like Marta’s Award goes to Marta!” she said with a laugh. Marta has played in six World Cups for Brazil and played this summer in her sixth Olympics, winning a silver medal after falling in the final to the United States . She previously said this would be her final year with the national team. But since then Brazil was named the host of the 2027 Women's World Cup. "I had a conversation with my coach, the national team coach, and I was really clear about playing in 2027. I told him it’s not my goal anymore,” she said. “But I’m always available to help the national team. And if they think I still can do something during this preparation for the World Cup, yeah, I would be happy to help them." Marta's club career started in Brazil when she was just 16. She has also played in Sweden and in the U.S. professional women's leagues that came before the NWSL. With nine regular-season goals, Marta has had one of her best seasons since she joined the Pride. “I can never pick a side, I never pick favorites — but I love to see this for Marta," U.S. coach Emma Hayes said. “Marta is someone we all like, admire and are grateful for. And that goal was just like prime Marta at her best. And so grateful for and thankful for her that she got the opportunity with another game with her team.” The Pride went 18-2-6 this season, clinching the NWSL Shield for the first trophy in club history. Orlando also set a record with 60 regular-season points to finish atop the standings. “We are sitting top of the table, but I think there still are a lot of doubters. I think there’s people out there who say, maybe this was a one-off season,” Strom said. “But we’re here to prove them all wrong. So I think we do carry a bit of that underdog mentality still with us.” The second-seeded Spirit advanced to the title match at Kansas City's CPKC Stadium last weekend on a penalty shootout after a 1-1 draw against defending champions Gotham FC. The Spirit's roster includes Trinity Rodman, a standout forward who formed the so-called “Triple Espresso” trio with Mallory Swanson and Sophia Smith for the United States at the Olympics. ___ AP soccer: https://apnews.com/hub/soccer

Texans foiled by mistake after mistake in 32-27 loss to TitansApiaries abuzz over ruling against widening cross-border trade in live honeybees

Disaster in the “margins” dooms ISU to 45-19 loss to Arizona State in Big 12 title game - Cyclone Fanatic

Cowboys' KaVontae Turpin reveals what he was thinking during epic kickoff return touchdown vs Commanders

None

Police Minister Mark Mitchell criticised cop posing with gang patch

Ex-OpenAI engineer who raised legal concerns about the technology he helped build has died